RAINBOW.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 12:00):

Stats
Dagens volum	78 541.00
Gjennomsnittsvolum	264 947
Markedsverdi	138.26B
EPS	INR6.20 ( 2023-10-30 )
Last Dividend	INR3.00 ( 2023-06-22 )
Next Dividend	INR0 ( N/A )
P/E	62.97
ATR14	INR2.12 (0.16%)

Volum Korrelasjon

Lang: 0.66 (moderate)

Kort: -0.48 (neutral)

Signal:(52.177) Neutral

Rainbow Children's Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Rainbow Children's Korrelasjon - Valuta/Råvare

0.01
( neutral )

-0.12
( neutral )

-0.67
( moderate negative )

0.02
( neutral )

-0.13
( neutral )

-0.44
( neutral )

Rainbow Children's Økonomi

Annual	2022
Omsetning:	INR11.74B
Bruttogevinst:	INR10.15B (86.51 %)
EPS:	INR20.89

FY	2022
Omsetning:	INR11.74B
Bruttogevinst:	INR10.15B (86.51 %)
EPS:	INR20.89

FY	2022
Omsetning:	INR9.74B
Bruttogevinst:	INR7.79B (80.00 %)
EPS:	INR13.62

FY	2021
Omsetning:	INR6.40B
Bruttogevinst:	INR5.37B (83.86 %)
EPS:	INR3.90

Financial Reports:

No articles found.

Rainbow Children's Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR2.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Rainbow Children's Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.46 - low (48.13%) | Divividend Growth Potential Score: 4.70 - Stable (5.91%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.00	2022-09-07
Last Dividend	INR3.00	2023-06-22
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR5.00	--
Avg. Dividend % Per Year	0.21%	--
Score	1.98	--
Div. Sustainability Score	4.46
Div.Growth Potential Score	4.70
Div. Directional Score	4.58	--

Next Divdend (Est)
(2024-09-30)

INR3.67 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

1.98

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR2.00	0.44%
2023	INR3.00	0.40%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
PSB.NS	No Dividend Player	2023-07-04	Sporadic	14	0.77%
KCP.NS	Dividend Junior	2023-08-10	Annually	23	0.55%
EIMCOELECO.NS	Dividend Knight	2023-06-16	Annually	23	0.80%
AGARIND.NS	Ex Dividend Junior	2023-09-08	Annually	11	0.44%
SUMICHEM.NS	Dividend Junior	2023-07-20	Annually	5	0.17%
NATCOPHARM.NS	Dividend Junior	2023-08-22	Semi-Annually	29	0.68%
HITECHCORP.NS	Dividend Junior	2023-06-30	Annually	17	0.30%
CANBK.NS	Dividend Junior	2023-06-14	Sporadic	22	1.58%
RICOAUTO.NS	Dividend Junior	2023-09-22	Annually	22	0.54%
L&TFH.NS	Dividend Junior	2023-07-21	Annually	12	0.77%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.173	1.500	6.55	9.82	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.199	1.500	8.90	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.12	1.000	8.85	8.85	[3 - 30]
operatingCashFlowPerShareTTM	20.20	2.00	3.27	6.53	[0 - 30]
freeCashFlowPerShareTTM	20.20	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.870	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.270	1.000	6.59	6.59	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.46

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	62.26	1.000	3.81	0	[1 - 100]
returnOnEquityTTM	0.199	2.50	9.29	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	20.20	2.00	3.27	10.00	[0 - 30]
dividendYielPercentageTTM	0.223	1.500	4.43	0	[0 - 0.4]
operatingCashFlowPerShareTTM	20.20	2.00	3.27	6.53	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.496	1.500	3.36	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.161	1.000	8.47	0	[0.1 - 0.5]
Total Score				4.70

Rainbow Children's

Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver diseases, hematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disease, and cranio-maxillofacial surgery; intensive care unit, bone marrow transplant unit, anesthesia and pain management, kidney transplant, cochlear implant services; genetics and metabolic medicines; and laboratory, speech and language therapy, occupational therapy, pediatric and metabolic medicine, developmental and behavioral pediatrics, cerebral palsy care services. Its women health services include obstetrics and gynecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after cesarean, breast feeding support, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company also provides fertility care services, such as fertility treatment, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, frozen embryo transfer, surgical sperm retrieval, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and 3 clinics in 6 cities with a total of 1,500 beds. The company was incorporated in 1998 and is based in Hyderabad, India.